Pelvic FloorUrinary IncontinenceAnal IncontinencePelvic Organ ProlapseSexual Dysfunction
Investigational drug(s) / intervention(s)
PFMTStandard care
PFMT: The motivation-informed intervention will tackle both exercise engagement and exercise adherence. Participating women will be introduced to the app and its videos following training. The participants will be introduced not only to muscle training, but also to muscle relaxation. The training will be recommended three to four times a week during pregnancy with further continuity after giving birth.
Standard care: Standard care
Study summary
The project seeks to investigate effectiveness of PFMT during pregnancy.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Woman in the 1st trimester of pregnancy (up to 12+6 weeks of gestation)
* Para 0 (no previous birth or pregnancy \> 16 weeks of gestation)
* Understands, writes, and reads fluently in Danish or English
* Has a smart phone or computer/tablet to reach the training program
Exclusion Criteria:
* Severe psychiatric illness (e.g. schizophrenia, bipolar disorder, severe depression or anxiety)
* Active substance abuse
* Acute social crises (e.g. homelessness, ongoing domestic violence, severe financial instability, lack of social support)
* Women with limited capacity to provide informed consent (due to cognitive impairment or language barriers)
* Previous pregnancy of \> 16 weeks of gestation
Primary outcome measure(s)
Urinary incontinence (UI) incidence at 3 months postpartum — At 3 months follow-up after giving birth International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) score between 0 (perfect continence) and 21 (total incontinence).
Trial sites (1)
Facility
City
Region
Status
Sygehus Sønderjylland
Aabenraa
Southern Denmark
Recruiting
More University of Southern Denmark trials in Denmark
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.